首页LAB • NASDAQ
add
流达公司
昨日收盘价
$1.65
当日价格范围
$1.55 - $1.66
年度波幅
$1.21 - $3.04
市值
6.14亿 USD
平均交易量
162.68万
市盈率
-
股息率
-
主要交易所
NASDAQ
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 4496.90万 | 77.27% |
经营支出 | 4755.90万 | 65.93% |
净收入 | -2693.80万 | -28.29% |
净利润率 | -59.90 | 27.63% |
每股收益 | -0.03 | 75.43% |
息税折旧摊销前利润 | -1792.90万 | -126.32% |
有效税率 | -0.44% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 3.66亿 | 184.31% |
总资产 | 6.82亿 | 100.88% |
负债总额 | 1.92亿 | 20.32% |
权益总额 | 4.89亿 | — |
发行在外的股份 | 3.72亿 | — |
市净率 | 1.26 | — |
资产回报率 | -8.74% | — |
资本回报率 | -10.30% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -2693.80万 | -28.29% |
来自运营的现金 | -2786.90万 | -144.21% |
投资现金 | -3088.30万 | 38.14% |
融资现金 | -2000.00 | 99.83% |
现金净变动 | -5916.20万 | 5.57% |
自由现金流 | -1321.72万 | -1,074.34% |
简介
Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations. Wikipedia
成立时间
1999
员工数量
537
